4.1 Article

Clinical application of blood purification in polymyositis/dermatomyositis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Hematology

Clinical parameters of therapeutic apheresis induction in clinically amyopathic dermatomyositis patients with rapid progressive interstitial lung disease

Maki Kagitani et al.

Summary: The study aims to clarify the clinical parameters of therapeutic apheresis (TA) induction in clinically amyopathic dermatomyositis patients with rapid progressive interstitial lung disease. The results indicate that the PaO2 to FiO2 (P/F) ratio is the only useful clinical parameter, and TA induction should be considered when the P/F ratio is lower than 174.

THERAPEUTIC APHERESIS AND DIALYSIS (2023)

Article Hematology

Experience of double plasma purification in 603 patients from a single center in Shanghai, China

Xiu Hong Yang et al.

Summary: Double plasma purification (DPP) is a rapid and effective treatment for severe hyperlipidemia and acute pancreatitis caused by severely high triglyceride levels. DPP provides an alternative treatment choice for patients intolerant to statins. The DPP process is safe and reliable.

THERAPEUTIC APHERESIS AND DIALYSIS (2023)

Article Hematology

Performance, clinical effectiveness, and safety of immunoadsorption in a wide range of indications

Kornelius Fuchs et al.

Summary: This study aimed to assess the performance, safety, and clinical effectiveness of immunoadsorption in patients with various autoimmune diseases. The results showed that the treatments with both GLOBAFFIN and Immunosorba were well tolerated, effective in lowering immunoglobulins, and led to clinical improvement or stabilization in the majority of patients.

THERAPEUTIC APHERESIS AND DIALYSIS (2022)

Article Rheumatology

Hierarchical cluster analysis of cytokine profiles reveals a cutaneous vasculitis-associated subgroup in dermatomyositis

Jingjing Bai et al.

Summary: The study identified multiple cytokine signatures in different subsets of patients with dermatomyositis, showing significant differences in levels of certain cytokines between active and stable disease groups. A combination of three specific cytokines demonstrated better performance in distinguishing between active and stable subsets. Additionally, a vasculitis-related subgroup was found in a specific subset based on cytokine profiles.

CLINICAL RHEUMATOLOGY (2021)

Article Biotechnology & Applied Microbiology

IL-6, IL-8, and IL-10 Are Associated with Hyperferritinemia in Rapidly Progressive Interstitial Lung Disease with Polymyositis/Dermatomyositis

Hidenaga Kawasumi et al.

BIOMED RESEARCH INTERNATIONAL (2014)

Article Cardiac & Cardiovascular Systems

The prognostic value of HRCT in myositis-associated interstitial lung disease

Kiminobu Tanizawa et al.

RESPIRATORY MEDICINE (2013)

Review Rheumatology

Clinically amyopathic dermatomyositis

Shinji Sato et al.

CURRENT OPINION IN RHEUMATOLOGY (2010)

Review Rheumatology

Interstitial lung disease in polymyositis and dermatomyositis: Clinical course and response to treatment

A Schnabel et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2003)